Ryan Savitz insider trades
Open-market stock purchases and sales by Ryan Savitz, EVP, CFO & CBO at Dianthus Therapeutics, Inc /DE/, from SEC Form 4 filings since Jan 24, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $568K |
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1M |
| Jul 9, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.6M |
| Apr 9, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Apr 9, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $739K |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $109K |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.7M |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $119K |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $65.1K |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $196K |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $5M |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $1.6M |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $619K |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Feb 3, 2026 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
| Dec 4, 2025 | DNTH Dianthus Therapeutics, Inc /DE/ | Sold | $904K |
| Dec 4, 2025 | DNTH Dianthus Therapeutics, Inc /DE/ | Bought (not open market) | — |
Companies traded
- DNTH Dianthus Therapeutics, Inc /DE/: 14 sales, last Jul 9, 2026